InBody Co.,Ltd

Total Valuation

InBody Co.,Ltd carries a market capitalization of 776.47B, placing it among publicly traded companies globally. Its enterprise value stands at 215.69B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

InBody Co.,Ltd currently has 12.19M shares outstanding.

Valuation Ratios

InBody Co.,Ltd trades at a trailing price-to-earnings ratio of 8.82. The price-to-sales ratio is 1.43, and the price-to-book ratio stands at 1.11.

Enterprise Valuation

On an enterprise value basis, InBody Co.,Ltd trades at an EV/EBITDA multiple of 5.04 and an EV/FCF ratio of 4.68. The EV/Sales ratio of 0.87 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 5.04 provides insight into valuation relative to core operating earnings.

Financial Position

InBody Co.,Ltd maintains a current ratio of 5.30, meaning it holds 5.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 2.57, indicating elevated leverage, while an interest coverage ratio of 83.73 demonstrates strong ability to service its debt obligations.

Financial Efficiency

InBody Co.,Ltd posts a return on equity of 13.31 and a return on invested capital of 11.04.

Taxes

Over the trailing twelve months, InBody Co.,Ltd has paid 9.09B in income taxes, reflecting an effective tax rate of 18.72.

Stock Price Statistics

InBody Co.,Ltd's stock has gained approximately 148.18763% over the past 52 weeks. The 50-day moving average sits at 42,903.00, while the 200-day moving average is 33,586.75.

Income Statement

Over the trailing twelve months, InBody Co.,Ltd generated 246.81B in revenue and converted that into 39.96B in net income, yielding earnings per share of 3,118.60. EBITDA reached 42.78B, while operating income came in at 42.78B.

Balance Sheet

InBody Co.,Ltd holds 147.10B in cash and equivalents against 8.48B in total debt, resulting in a net debt position of -61.50B. Total book value stands at 316.22B, with working capital of 186.79B providing operational flexibility.

Cash Flow

InBody Co.,Ltd produced 38.17B in operating cash flow over the past twelve months. After subtracting -7.49B in capital expenditures, free cash flow totaled 30.67B - equivalent to 2,402.44 per share.

Margins

InBody Co.,Ltd operates with a gross margin of 77.07, reflecting its pricing power and cost economics. The operating margin of 17.33 and net profit margin of 16.19 provide insight into operational efficiency.

Dividends & Yields

Stock Splits

InBody Co.,Ltd's most recent stock split took place on April 23, 2010 with a 1:2 split ratio.

Scores

InBody Co.,Ltd posts an Altman Z-Score of 6.94, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.